Clinical Profile of Patients with Post-COVID-19 Mucormycosis at a Tertiary Care Center
Background: Mucormycosis is a serious but rare fungal infection, but there was an increase in incidence in the COVID-19 phase. The study aims to throw light on the possible reasons and possible treatment options for optimal outcomes. Objectives: The study aims to formulate the clinical profile of pa...
Saved in:
| Main Authors: | S. Anju, K. A. Ameer, P. Arjun, Sujith Varghese Abraham |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2025-07-01
|
| Series: | Journal of Advanced Lung Health |
| Subjects: | |
| Online Access: | https://journals.lww.com/10.4103/jalh.jalh_65_24 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A battle within the war - Mucormycosis: The Black fungus disease in India during COVID - 19
by: Sujeeth Modaboyina, et al.
Published: (2022-01-01) -
Outcomes of COVID‐19‐associated mucormycosis epidemic in India: A prospective 2‐year follow‐up study
by: Vishav Yadav, et al.
Published: (2025-03-01) -
Endovascular Infusion of Amphotericin B for the Treatment of Rhino-Orbito-Cerebral Mucormycosis: A Pilot Study Assessing Technical Feasibility and Safety
by: Subhash Kumar, et al.
Published: (2022-07-01) -
Increased serum ferritin is associated with severity of orbital disease in COVID-19–associated rhino-orbito-cerebral mucormycosis: A quantitative analysis
by: Shashi Tanwar, et al.
Published: (2025-02-01) -
Mucormycosis in patients with COVID-19 in Russia: the results of a prospective multi-center study
by: S. N. Khostelidi, et al.
Published: (2022-07-01)